文献速递咽喉与嗓音

喉返神经再支配与I型甲状软骨成形术治疗单侧声带麻痹(VOCALIST):一项随机可行性研究

Laryngeal Reinnervation vs Type I Thyroplasty in Unilateral Vocal Fold Paralysis (VOCALIST): A Randomized Feasibility Study.
PubMed 文献 · Laryngoscope · 2025-05-05

该可行性研究在英國三个中心招募27例单侧声带麻痹成人,23例随机分配至喉返神经再支配组(n=12)或I型甲状软骨成形术组(n=11),96%(n=22)接受分配治疗,17例在研究结束前接受干预,随访至12个月,主观与客观嗓音、吞咽及生活质量指标显示对干预变化有反应性,结论为在英国开展足效能随机对照试验在实施、招募、结局测量和完成方面可行。

要点

  • 23例单侧声带麻痹患者随机分配至喉返神经再支配组(n=12)或I型甲状软骨成形术组(n=11)。
  • 96%(n=22)参与者接受分配治疗,17例在研究结束前接受干预。
  • 主观与客观嗓音、吞咽及生活质量结局指标显示对干预变化有反应性。

核心结论

  • 研究结果为确保在英国开展喉返神经再支配与I型甲状软骨成形术治疗成人单侧声带麻痹的足效能随机对照临床试验在实施、招募、结局测量和完成方面可行提供了保证。

研究设计与样本

  • 可行性研究,在英国三个中心招募27例参与者,试验流程模拟完整试验,随访至12个月,并行定性研究。

主要发现

  • 招募成功,23例单侧声带麻痹患者随机分配至喉返神经再支配组(n=12)和甲状软骨成形术组(n=11)。
  • 96%(n=22)参与者接受其被分配的治疗,其中17例在研究结束日期前接受干预。
  • 定性研究识别出可通过试验内培训解决的次要招募挑战。
  • 所使用的主观和客观嗓音、吞咽及生活质量结局指标显示对干预后变化有反应性。

局限性

  • 定性研究识别出次要招募挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We wished to determine the feasibility of performing a multi-centre phase III randomized controlled trial that compares laryngeal reinnervation to type I thyroplasty for adults with unilateral vocal fold paralysis (UVFP) in the UK. METHODS: A feasibility study was designed; 27 participants were recruited at three UK sites. Trial procedures mirrored those intended for a full-scale trial. We assessed recruitment rates, acceptability of randomization, and dropout rates and conducted a qualitative study to understand the recruitment processes. Participants were followed up for up to 12 months to assess optimal outcome measures for the definitive trial covering voice, swallowing, and overall quality of life. A qualitative study was run in parallel with the quantitative clinical trial. RESULTS: Recruitment was successful with 23 patients with UVFP randomized to reinnervation (n = 12) and thyroplasty (n = 11). 96% (n = 22) of participants accepted the treatment to which they were allocated, of which 17 received their intervention before the study end date. The qualitative study identified minor recruitment challenges that could be addressed through in-trial training. The set of subjective and objective voice, swallowing, and quality of life outcome measures used demonstrated a responsiveness to change following interventions. CONCLUSION: The results from this study have provided us with the assurance that conducting an adequately powered randomized controlled clinical trial of laryngeal reinnervation versus type I thyroplasty for adults with UVFP in the UK is feasible in terms of conduct, recruitment, outcome measurement, and completion. TRIAL REGISTRATION: ISRCTN90201732.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Birchall M, Iliadou E, Blackshaw H, et al. Laryngeal Reinnervation vs Type I Thyroplasty in Unilateral Vocal Fold Paralysis (VOCALIST): A Randomized Feasibility Study. Laryngoscope. 2025. PMID: 40323143. doi:10.1002/lary.32230

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。